New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Updated on: July 17,2024 0

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Updated on:July 17,2024 0

Two new studies show how bacteria could help tumors progress and resist treatment

byFred Hutchinson Cancer Research CenterCredit: CC0 Public DomainTwo new studies from researchers at Fred Hutchinson Cancer Center in Seattle reveal how bacteria infiltrate tumors and could be h

Updated on: December 28,2023 10

Two new studies show how bacteria could help tumors progress and resist treatment

byFred Hutchinson Cancer Research CenterCredit: CC0 Public DomainTwo new studies from researchers at Fred Hutchinson Cancer Center in Seattle reveal how bacteria infiltrate tumors and could be h

Updated on:December 28,2023 10

Less than half of pregnant women get the flu shot: New data from UPMC Children's might change that

by Abby Mackey, Pittsburgh Post-GazetteCredit: Unsplash/CC0 Public DomainJohn Williams knows the risks associated with riding motorcycles, but they don't deter him. Neither do warnings from physic

Updated on: March 25,2024 10

Less than half of pregnant women get the flu shot: New data from UPMC Children's might change that

by Abby Mackey, Pittsburgh Post-GazetteCredit: Unsplash/CC0 Public DomainJohn Williams knows the risks associated with riding motorcycles, but they don't deter him. Neither do warnings from physic

Updated on:March 25,2024 10

Key discovery advances fight to reduce breast cancer recurrence

byDuke-NUS Medical SchoolLoss of Gα13 in ER+ breast cancer cells leads to increased cell growth and tumour development, suggesting that Gα13 may suppress tumours in this subtype of cancer. Credi

Updated on: September 06,2024 0

Key discovery advances fight to reduce breast cancer recurrence

byDuke-NUS Medical SchoolLoss of Gα13 in ER+ breast cancer cells leads to increased cell growth and tumour development, suggesting that Gα13 may suppress tumours in this subtype of cancer. Credi

Updated on:September 06,2024 0

Long-term study reveals more genetic mutations associated with aggressive prostate cancer

byInstitute of Cancer ResearchXenograft model of prostate cancer. Credit: National Institutes of Health, 2015Scientists have added to the list of inherited genetic mutations known to increase th

Updated on: July 08,2024 0

Long-term study reveals more genetic mutations associated with aggressive prostate cancer

byInstitute of Cancer ResearchXenograft model of prostate cancer. Credit: National Institutes of Health, 2015Scientists have added to the list of inherited genetic mutations known to increase th

Updated on:July 08,2024 0

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym

Updated on: December 01,2024 0

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym

Updated on:December 01,2024 0

Massive drug search uncovers infinitesimal molecule that kills cancers while sparing immune cells

by Delthia Ricks , Medical XpressN6F11 suppresses the growth of human PDAC. (A) PANC1 cells were pretreated with DMSO or N6F11 (5 µM) for 12 hours. (B) MiaPACA2 cells were pretreated with DMSO or N6F1

Updated on: December 30,2023 11

Massive drug search uncovers infinitesimal molecule that kills cancers while sparing immune cells

by Delthia Ricks , Medical XpressN6F11 suppresses the growth of human PDAC. (A) PANC1 cells were pretreated with DMSO or N6F11 (5 µM) for 12 hours. (B) MiaPACA2 cells were pretreated with DMSO or N6F1

Updated on:December 30,2023 11

Combining neurologic and blood pressure drugs reduces breast tumor development in mice

byGeorgetown University Medical CenterCancer cell during cell division. Credit: National Institutes of HealthAdding a medication used to treat epilepsy, bipolar disorder and migraines to a blood

Updated on: December 22,2023 20

Combining neurologic and blood pressure drugs reduces breast tumor development in mice

byGeorgetown University Medical CenterCancer cell during cell division. Credit: National Institutes of HealthAdding a medication used to treat epilepsy, bipolar disorder and migraines to a blood

Updated on:December 22,2023 20

Colorectal cancer gene implicated in broad range of solid tumors

by Amy Mone, Valerie Mehl,Johns Hopkins UniversityMUTYH-altered samples. (A) CONSORT diagram showing grouping of samples. Samples with somatic MUTYH alterations including pathogenic short varian

Updated on: March 27,2024 0

Colorectal cancer gene implicated in broad range of solid tumors

by Amy Mone, Valerie Mehl,Johns Hopkins UniversityMUTYH-altered samples. (A) CONSORT diagram showing grouping of samples. Samples with somatic MUTYH alterations including pathogenic short varian

Updated on:March 27,2024 0

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on: January 02,2024 9

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on:January 02,2024 9

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca

Updated on: January 26,2024 24

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca

Updated on:January 26,2024 24

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on: June 01,2024 5

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on:June 01,2024 5